# Accelerating Excellence in Translational Science (AXIS)

> **NIH NIH U54** · CHARLES R. DREW UNIVERSITY OF MED & SCI · 2022 · $358,750

## Abstract

Abstract: Proposed Program Overview. The Charles R. Drew University of Medicine and Science proposes
to continue the enhancement and success of the Accelerating Excellence in Translational Science (AXIS)
Center. AXIS has shown to be the integrated hub for research conducted at CDU and continues to provide
experienced leadership, and a myriad of clinical, translational, and community partnered activities. In the next
five years, research will continue to grow and expand its enterprise alongside the Universities vision and mission
to be a leader in eliminating health disparities by translating scientific discoveries into education, training, clinical
care, treatment, and community service in three areas of focus which disproportionally affect Service Planning
Area 6: Cancer, Cardiometabolic Disease (CMD), and HIV/AIDS. In addition, we look to build upon the
application of Precision Medicine to understand and eliminate health disparities, while utilizing many of CDU’s
outstanding resources in: Advanced Technologies such as Next Generation Sequencing for identifying Genomic
Data; Drug Discovery; Integrated Clinical Tissues, Biorepository and Bio banking Facility; Clinical Studies/Trials
Resources; Medical Bioinformatics; and Methods for Statistical and Epidemiological Studies. This approach will
pave the pathway for CDU’s in becoming a competitive institution with sophisticated resources and services to
better serve our communities. To accomplish this, we propose to continue with the three programmatic goals
that align with the mission, vision, and strategic plan for the universities research enterprise:
Goal 1: To enhance the infrastructure capacity in translational research using Precision Medicine model in the
areas of Cancer, Cardiometabolic, and HIV/AIDS. Provide support for the emerging research pillars in Mental
Health and Health Services
Goal 2: To continue the integration of basic, clinical, behavioral and community-partnered research by fostering
collaboration among disciplines, departments and schools at CDU, and sustainable collaboration with community
leaders and investigators across other research institutions.
Goal 3: To facilitate and elevate professional development and best practices in mentored clinical and
translational research training on minority health and health disparities.

## Key facts

- **NIH application ID:** 10499224
- **Project number:** 3U54MD007598-14S1
- **Recipient organization:** CHARLES R. DREW UNIVERSITY OF MED & SCI
- **Principal Investigator:** Jaydutt V. Vadgama
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $358,750
- **Award type:** 3
- **Project period:** 2009-09-28 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10499224

## Citation

> US National Institutes of Health, RePORTER application 10499224, Accelerating Excellence in Translational Science (AXIS) (3U54MD007598-14S1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10499224. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*